Common Stock, Shares, Outstanding of Arena Group Holdings, Inc. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Arena Group Holdings, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2010 to Q3 2025.
  • Arena Group Holdings, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 47.6M shares, a 0.28% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Arena Group Holdings, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 47.6M +130K +0.28% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 47.6M +18M +60.8% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 47.6M +18M +61.1% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 47.6M +23.7M +99.5% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 47.4M +23.6M +99.2% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 29.6M +7.56M +34.3% 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 29.5M +7.74M +35.6% 31 Mar 2024 10-Q 17 May 2024
Q4 2023 23.8M +5.53M +30.2% 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 23.8M +5.67M +31.3% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 22M +4.19M +23.5% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 21.8M +4.27M +24.4% 31 Mar 2023 10-Q 10 May 2023
Q4 2022 18.3M +5.67M +44.9% 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 18.1M -246M -93.1% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 17.8M -245M -93.2% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 17.5M -213M -92.4% 31 Mar 2022 10-Q 04 May 2022
Q4 2021 12.6M +2.22M +21.3% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 264M +224M +552% 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 263M +225M +582% 30 Jun 2021 10-Q 16 Aug 2021
Q1 2021 230M +193M +515% 31 Mar 2021 10-Q 16 Aug 2021
Q4 2020 10.4M -26.7M -71.9% 31 Dec 2020 10-K 01 Apr 2022
Q3 2020 40.5M +3.19M +8.55% 30 Sep 2020 10-Q 18 May 2021
Q2 2020 38.6M +1.65M +4.47% 30 Jun 2020 10-Q 12 May 2021
Q1 2020 37.5M -211K -0.56% 31 Mar 2020 10-Q 07 May 2021
Q4 2019 37.1M +1.35M +3.78% 31 Dec 2019 10-K 16 Aug 2021
Q3 2019 37.4M +3.89M +11.6% 30 Sep 2019 10-K 09 Apr 2021
Q2 2019 36.9M +5.82M +18.7% 30 Jun 2019 10-K 09 Apr 2021
Q1 2019 37.7M +7.47M +24.7% 31 Mar 2019 10-K 09 Apr 2021
Q4 2018 35.8M +7.25M +25.4% 31 Dec 2018 10-K 09 Apr 2021
Q3 2018 33.5M +7.46M +28.7% 30 Sep 2018 10-Q 18 May 2020
Q2 2018 31.1M +5.14M +19.8% 30 Jun 2018 10-Q/A 16 Aug 2019
Q1 2018 30.2M +8.16M +37% 31 Mar 2018 10-Q 27 Jun 2018
Q4 2017 28.5M +6.47M +29.3% 31 Dec 2017 10-K 08 Jan 2021
Q3 2017 26M +16.5M +174% 30 Sep 2017 10-Q 14 Nov 2017
Q2 2017 26M +16.6M +176% 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 22.1M +12.7M +135% 31 Mar 2017 10-Q 22 May 2017
Q4 2016 22M +12.8M +138% 31 Dec 2016 10-K 15 May 2018
Q3 2016 9.48M +284K +3.09% 30 Sep 2016 10-Q 31 Oct 2016
Q2 2016 9.42M +309K +3.39% 30 Jun 2016 10-Q 15 Aug 2016
Q1 2016 9.37M +333K +3.69% 31 Mar 2016 10-Q 16 May 2016
Q4 2015 9.28M +333K +3.73% 31 Dec 2015 10-Q 31 Oct 2016
Q3 2015 9.2M +319K +3.6% 30 Sep 2015 10-Q 16 Nov 2015
Q2 2015 9.12M +314K +3.57% 30 Jun 2015 10-Q 14 Aug 2015
Q1 2015 9.03M +304K +3.49% 31 Mar 2015 10-Q 15 May 2015
Q4 2014 8.95M +299K +3.46% 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 8.88M +319K +3.73% 30 Sep 2014 10-Q 14 Nov 2014
Q2 2014 8.8M +319K +3.76% 30 Jun 2014 10-Q 05 Aug 2014
Q1 2014 8.73M +332K +3.96% 31 Mar 2014 10-Q 15 May 2014
Q4 2013 8.65M +332K +4% 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 8.56M +321K +3.9% 30 Sep 2013 10-Q 14 Nov 2013
Q2 2013 8.48M +321K +3.94% 30 Jun 2013 10-Q 13 Aug 2013
Q1 2013 8.4M +302K +3.74% 31 Mar 2013 10-Q 15 May 2013
Q4 2012 8.32M +289K +3.6% 31 Dec 2012 10-K 31 Mar 2014
Q3 2012 8.24M +267K +3.35% 30 Sep 2012 10-Q 14 Nov 2012
Q2 2012 8.16M +231K +2.91% 30 Jun 2012 10-Q/A 05 Sep 2012
Q1 2012 8.09M 31 Mar 2012 10-Q 11 May 2012
Q4 2011 8.03M +206K +2.64% 31 Dec 2011 10-K 01 Apr 2013
Q3 2011 7.97M 30 Sep 2011 10-Q 08 Nov 2011
Q2 2011 7.93M 30 Jun 2011 10-Q 02 Aug 2011
Q4 2010 7.82M 31 Dec 2010 10-K 28 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.